British Military Chaplaincy in Early Victorian India by Michael Snape

Get full text

The MAP (Me-As-a-Process) coaching model: a framework for coaching women’s identity work in voluntary career transitions by Sarah Snape

Get full text

Persistence of immune responses induced by Ebola virus vaccines. by Snape, M

Dynamics of environmental bioprocesses : modelling and simulation / by Snape, Jonathan B.

Dynamics of environmental bioprocesses : modelling and simulation / [disket] by Snape, Jonathan B.

COVID-19 in children and young people by Snape, MD, Viner, RM

No evidence for capsule replacement...and Wales - Authors' Reply by Snape, M, Pollard, A

Erratum: Meningococcal polysaccharide-protein conjugate vaccines (Lancet Infective Diseases (2005) 5 (21-30) by Snape, MD, Pollard, A

Immunisation of adolescents in the UK. by Kale, A, Snape, MD

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease. by Su, E, Snape, MD

The price of prevention: what now for immunisation against meningococcus B? by Moxon, R, Snape, MD

Fine with five? Shorter antibiotic courses for childhood meningitis. by Snape, MD, Kelly, D

The beginning of the end for serogroup B meningococcus? by Snape, MD, Pollard, A

African tick bite fever. by Snape, MD, Pollard, A

Emerging clinical experience with vaccines against group B meningococcal disease by Wilkins, A, Snape, M

Where next? The emergence of hypervirulent W meningococcus in the Netherlands by Snape, M, Broad, J

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply by Snape, MD, Pollard, A

Meningococcal polysaccharide-protein conjugate vaccines (vol 5, pg 21, 2005) by Snape, MD, Pollard, A

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. by Barker, C, Snape, MD

Meningococcal polysaccharide-protein conjugate vaccines. by Snape, MD, Pollard, A